Bollard Group’s Thermo Fisher Scientific TMO Stock Holding History

Bollard Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31.1M	Hold	62,107	–	–	0.95%	18
2026 Q1	$30.5M	Buy	62,107 +107	+0.2%	+$58.1K	0.9%	18
2025 Q4	$35.9M	Sell	62,000 -1	-0%	-$566	0.9%	15
2025 Q3	$30.1M	Hold	62,001	–	–	0.71%	20
2025 Q2	$25.1M	Buy	62,001 +62,000	+6,200,000%	+$25.9M	0.57%	23
2025 Q1	$0	Hold	1	–	–	﹤0.01%	287
2024 Q4	$0	Sell	1 -111,254	-100%	-$61.2M	﹤0.01%	302
2024 Q3	$68.8M	Buy	111,255 +2,804	+3%	+$1.66M	1.83%	10
2024 Q2	$60M	Hold	108,451	–	–	1.69%	10
2024 Q1	$63M	Buy	108,451 +3,528	+3%	+$1.98M	1.91%	9
2023 Q4	$55.7M	Hold	104,923	–	–	1.94%	9
2023 Q3	$53.1M	Sell	104,923 -1,562	-1%	-$832K	1.95%	9
2023 Q2	$55.6M	Hold	106,485	–	–	1.89%	7
2023 Q1	$61.4M	Buy	106,485 +106,484	+10,648,400%	+$60M	2.22%	7
2022 Q4	$0	Hold	1	–	–	﹤0.01%	293
2022 Q3	$0	Sell	1 -204	-100%	-$114K	﹤0.01%	298
2022 Q2	$111K	Sell	205 -1,271	-86%	-$700K	﹤0.01%	196
2022 Q1	$872K	Hold	1,476	–	–	0.03%	144
2021 Q4	$985K	Buy	1,476 +1	+0.1%	+$624	0.03%	140
2021 Q3	$843K	Buy	1,475 +1	+0.1%	+$549	0.03%	143
2021 Q2	$744K	Hold	1,474	–	–	0.02%	150
2021 Q1	$673K	Hold	1,474	–	–	0.02%	145
2020 Q4	$687K	Hold	1,474	–	–	0.03%	136
2020 Q3	$651K	Hold	1,474	–	–	0.02%	139
2020 Q2	$534K	Buy	1,474 +1,270	+623%	+$426K	0.02%	133
2020 Q1	$58K	Hold	204	–	–	﹤0.01%	169
2019 Q4	$66K	Hold	204	–	–	﹤0.01%	183
2019 Q3	$59K	Hold	204	–	–	﹤0.01%	194
2019 Q2	$60K	Hold	204	–	–	﹤0.01%	207
2019 Q1	$56K	Buy	204 +1	+0.5%	+$249	﹤0.01%	208
2018 Q4	$46K	Hold	203	–	–	﹤0.01%	208
2018 Q3	$50K	Hold	203	–	–	﹤0.01%	216
2018 Q2	$42K	Hold	203	–	–	﹤0.01%	213
2018 Q1	$42K	Hold	203	–	–	﹤0.01%	216
2017 Q4	$38K	Hold	203	–	–	﹤0.01%	211
2017 Q3	$38K	Buy	203 +1	+0.5%	+$181	﹤0.01%	221
2017 Q2	$35K	Hold	202	–	–	﹤0.01%	231
2017 Q1	$31K	Hold	202	–	–	﹤0.01%	235
2016 Q4	$29K	Hold	202	–	–	﹤0.01%	235
2016 Q3	$32K	Hold	202	–	–	﹤0.01%	225
2016 Q2	$30K	Buy	202 +1	+0.5%	+$148	﹤0.01%	221
2016 Q1	$29K	Hold	201	–	–	﹤0.01%	224
2015 Q4	$29K	Hold	201	–	–	﹤0.01%	227
2015 Q3	$25K	Hold	201	–	–	﹤0.01%	245
2015 Q2	$26K	Buy	201 +1	+0.5%	+$130	﹤0.01%	240
2015 Q1	$27K	Hold	200	–	–	﹤0.01%	241
2014 Q4	$25K	Hold	200	–	–	﹤0.01%	238
2014 Q3	$24K	Buy	+200	New	+$24.3K	﹤0.01%	250

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bollard Group's TMO Position: Q2 2026 in Review

Bollard Group held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 62,107 shares worth $31.1M. The position accounts for 0.95% of the portfolio, ranked #18.

Bollard Group first reported a position in TMO in Q3 2014 and has held it in 48 quarters since. The position peaked at $68.8M in Q3 2024. 2,604 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Bollard Group held 62,107 shares of Thermo Fisher Scientific worth $31.1M as of Q2 2026.
Bollard Group left its Thermo Fisher Scientific share count unchanged in Q2 2026.
Thermo Fisher Scientific made up 0.95% of Bollard Group's portfolio in Q2 2026, its #18 holding.
Bollard Group first reported a position in Thermo Fisher Scientific in Q3 2014 and has held it in 48 quarters since.
Bollard Group's Thermo Fisher Scientific position peaked at $68.8M in Q3 2024.
2,604 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Bollard Group's 13F filing for Q2 2026, filed 12 Aug 2026.